René Fiasse

Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene Polymorphism

Édouard Louis, Séverine Vermeire, P. Rutgeerts et al. · Scandinavian Journal of Gastroenterology · 2002 · 242 citations · Full text

Veterinary Medicine, Clinical Sciences, Immunology +14

Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease

Séverine Vermeire, Édouard Louis, An Carbonez et al. · The American Journal of Gastroenterology · 2002 · 225 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene Polymorphism

Édouard Louis, Séverine Vermeire, P. Rutgeerts et al. · Scandinavian Journal of Gastroenterology · 2002 · 223 citations

Veterinary Medicine, Clinical Sciences, Immunology +14

Efficacy and Safety of Prolonged-Release Lanreotide in Patients With Gastrointestinal Neuroendocrine Tumors and Hormone-Related Symptoms

A.N.M. Wymenga, Barbro Eriksson, Pasi Salmela et al. · Journal of Clinical Oncology · 1999 · 223 citations

Medicine, Oncology, Pharmacotherapy +17

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

Séverine Vermeire, Édouard Louis, Paul Rutgeerts et al. · Gastroenterology · 2002 · 207 citations · Full text

Veterinary Medicine, Immunology, Internal Medicine +10